Algiers – Algeria launched the production of Coronavirus testing kits on Monday with a first volume of 200,000 units/ week with rapid 15 mns results, a first in the Maghreb history, public television (EPTV) announced.

Located in Baba Ali (West of Algiers), Vital Care production plant (100% Algerian) of these kits will allow, in addition to record results, diagnose cases of contamination of asymptomatic individuals, according to the source.

A test considered as satisfactory of these screening kits has already been carried out at Beni Messous University Hospital Center (Algiers).

Algeria thus becomes the first Maghreb country to produce such tests and the second in Africa, following South Africa.

These tests will be produced at a rate of 200,000 units per week, by the Algerian company, Vital Care based in Baba Ali (Algiers), explained the acting minister responsible for pharmaceutical production, Mr. Lotfi Benbahmed.

To date, Algeria has adopted the protocol for treating the coronavirus with hydroxy-chloroquine, produced locally even before the outbreak of the epidemic, while hundreds of companies and associations were producing masks and disinfectant gels. This protocol, combined with antivirals, has helped to cure, to date, 2841 people, including 163 during the last 24 hours.

The Minister of Health, Population and Hospital Reform, Prof. Abderrahmane Benbouzid, said that the indicators for the use of this therapeutic protocol against COVID-19 were “encouraging and very satisfactory”, since there is “fewer deaths”.

In addition to the implementation of the protocol, the new plant at Baba Ali will now allow Algeria to reach a certain autonomy in terms of screening and treatment of the pandemic.

Article published on Algeria press service

Source :